Anti-CD38 Monoclonal Antibodies: An Emerging Therapeutic Target in Nephrology with Broad Clinical Implications

Zenodo (CERN European Organization for Nuclear Research) 2026 Preprint Open access

Read full text
Authors: Aris Tsalouchos
DOI: 10.5281/zenodo.19038893
Cited by: 0

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Renal Diseases and Glomerulopathies Chronic Kidney Disease and Diabetes

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
15 March 2026
Language
EN
Document type
Preprint